1216 PDF
1216 PDF
1216 PDF
Review Article
www.ijrap.net
*Corresponding author
Dr. R. Rathinamala M. D(s), Ph. D Scholar, Department of Gunapadam, National Institute of Siddha, Tambaram sanatorium, Chennai, India
E-mail: drrmala@yahoo.com
DOI: 10.7897/2277-4343.05376
ABSTRACT
The marine ecosystem is a rich source of drug discovery and development. Pharmacological investigations of marine products are providing
convincing evidence that marine drug discovery has an exceedingly bright future in health care. The availability of ethno medicinal literature about
marine products is very limited. Marine organisms have been used in Siddha system of Medicine since time immemorial. Pavalam (Red coral) is a
valuable mineral drug which is commonly used in day to day practice by Siddha physicians for various ailments. This paper focuses on its origin,
character, purification and processing techniques and different form of medicines prepared. The literature review revealed that Pavalam based
medicines are widely used for the management of respiratory diseases, bleeding disorders and life style diseases like cancer and diabetes. The various
research reports on Pavalam through scientific validation also highlighted for its future development. The scientific reports confirm the traditional
claim of Pavalams efficacy.
Keywords: Pavalam, red coral, Siddha system, mineral drug, research, scientific validation
367
Rathinamala Rathinam et al / Int. J. Res. Ayurveda Pharm. 5(3), May - Jun 2014
368
Rathinamala Rathinam et al / Int. J. Res. Ayurveda Pharm. 5(3), May - Jun 2014
width and cross-sectional area in treatment group. The rats. Liver damage was induced by CCl4 in wistar rats.
combined cortical thickness and cortical and periosteal The liver damage was assessed by heamatological and
area ratio are also increased compared to sham operated biochemical parameters. The animals treated with Kodi
animals. Scanning electron microscopy (SEM) study Pavala Chunnam showed near normal levels in
showed porous and erosive appearance of the distal femur haematological, biochemical parameters which indicate
at the epiphysis and reduced Ca/P ratio in ovariectomised the hepato-protective activity of Pavalam against CCl4
animals was also reversed compared to SHAM and drug induced liver damage.
treated group.31
Clinical trials
Anti atherosclerotic activity Pravala hasma in hyperacidity patients
The effect of orally administered Anna pavala Two samples of Pravala Mula bhasma (Bhasma prepared
chendooram, was investigated on experimental from Tubiphora musica) and two samples of Pravala
atherosclerosis. Rabbits were fed with a cholesterol rich Shakha bhasma (bhasma prepared from Corallium
(0.5 %) diet for 6 months to induce atherosclerosis. These rubrum) were prepared and studied in patients with
animals were divided into various groups of treatment. hyperacidity (Amlapitta) for a period of 21 days. The
The treated group was given 50 mg of Anna pavala cardinal and associated symptoms were carefully noticed
chendooram/day/animal for a period of further 6 months. and scored. Results of the study suggested that the effect
At the end of the experiment, plasma and aortic lipid of Pravala Shakha bhasma was better than that of Pravala
components were estimated and the atherosclerotic mula bhasma.37
lesions of the aorta were quantified by histological
examination. Changes in the metabolism of plasma and Kodipavala chunnam in hepatitis patients
aortic phospholipids were studied by fractionation into The drug Kodipavala chunnam was evaluated for
individual lipids following the incorporation of radiolabel hepatoprotective activity in patients with infective
from14 C-acetate into phospholipids. The plasma hepatitis, drug induced hepatitis and alcoholic hepatitis.
cholesterol level was reduced up to 65 % and the HDL The drug was given to the patients at the dose of 100 to
level was increased. The atheroma formation was also 200 mg thrice daily with honey for a period of 28 days.
inhibited. Anna pavala chendooram reduced the plasma The levels of serum bilirubin, ALP, AST, SAP and GGT
sphingomyelin levels32,33. were monitored before and after the treatment. It was
noticed that the elevated biochemical parameters of liver
Haemostatic activity were restored to normal levels with the usage of
The drug Pavala parpam was evaluated for haemostatic Kodipavala chunnam.38
activity in Swiss albino mice. In acute toxicity study, the
drug was found to be safe up to 2000 mg/kg body weight CONCLUSION
in Swiss albino mice. The animals were treated with 500 The literature search in Siddha classical texts revealed
mg/kg body weight /p.o. After the administration of that Pavalam plays a major role in the management of
Pavala Parpam the treated animals blood showed marked diseases like diabetes, bronchial asthma, tuberculosis,
reduction in both bleeding and clotting time when hepatitis and bleeding disorders. The toxicity studies done
compared to untreated control animals blood. There was on Pavala parpam and Kodipavala chunnam prove that the
also significant reduction in bleeding that was well internal administration of the drug is safe up to 2000
comparable to that of standard adrenochrome, a mg/kg and 4000 mg/kg body weight respectively. The
haemostatic drug34. scientific validations which were done on Pavalam proved
its the traditional claim. At the same time, the clinical
Hepato-protective activity trials which were conducted in a small size of patients
The acute and 28 days repeated oral toxicity studies on were not adequate and the animal studies are only
Kodi pavala chunnam was carried out as per OECD preliminary studies. Further studies are required to
guidelines. In acute toxicity study it was found that Kodi explore the genotoxicity, pharmacokinetics and well
pavala chunnam was found to be non toxic upto 4000 randomized control trials to strengthen the traditional
mg/kg. In repeated oral toxicity, except mild diarrhea, claim. This review justifies the continuous use of Pavalam
Kodi pavala chunnam did not exhibit any signs of in Siddha system of medicine for various ailments.
intoxication in the animals. Kodi pavala chunnam was
evaluated for its hepatoprotective activity in experimental
369
Rathinamala Rathinam et al / Int. J. Res. Ayurveda Pharm. 5(3), May - Jun 2014
370
Rathinamala Rathinam et al / Int. J. Res. Ayurveda Pharm. 5(3), May - Jun 2014
371